Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
Edit Symbol List
Symbol Lookup
LIFE: Stock Quote & Summary Data
0.62%
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | $ 56.50 |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 2,090,848 |
| Previous Close | $ 49.79 |
| 52 Wk High / Low | $ 51.33 / $ 19.56 |
| Shares Outstanding | 176,339,000 |
| Market Value | $ 8,725,253,720 |
| P/E Ratio | 16.12 |
| Forward P/E (1yr) | 15.02 |
| Earnings Per Share | $ 3.07 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 0.91 |
| NASDAQ Official Open Price: | $ 49.50 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 49.48 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About LIFE?
Ask your question about about Life Technologies Corporation (LIFE) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
We began operations as a California partnership in 1987 and incorporated in California in 1989. In 1997 we reincorporated as a Delaware corporation. Our principal offices are in Carlsbad, California. Our website is http://www.invitrogen.com. This Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, our Current Reports on Form 8-K and any amendments thereto are made available without charge on our website. We have made a number of significant acquisitions over the past several years that have expanded our overall size and the breadth of the products we offer, including the 2007 acquisition of Cascade Biologics, Inc. and Genomed GmbH, the 2006 acquisition of Sentigen Holding Corp. and the asset purchase of Xcyte Therapies, Inc. (Xcyte), and the 2005 acquisitions of Dynal Biotech Holding AS (Dynal), BioSource International, Inc. (BioSource), Caltag Laboratories (Caltag) and Zymed Laboratories, Inc. (Zymed). ... More ...
Links to all Life Technologies Corporation (LIFE) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for LIFE |
||
|
2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer - PR Newswire 11/16/2009 6:01PM |
||
|
Life Technologies Addresses Promise of Cell Therapies at Industry Leader Summit - Business Wire 11/12/2009 7:30AM |
||
|
Life Tech. Inks Definitive Deal To Buy BioTrove - Quick Facts - RTT News 11/10/2009 9:14AM |
||
|
Life Technologies Signs Definitive Agreement to Acquire BioTrove - Business Wire 11/10/2009 9:08AM |
||
|
University of Cambridge and Life Technologies Collaborate on Landmark High Throughput Sequencing Hub in United Kingdom - Business Wire 11/10/2009 7:30AM |
||
|
Qiagen Q3 Profit Soars, Beats View; Tightens FY09 Earnings View - Update - RTT News 11/09/2009 6:47PM |
||
|
Life Technologies Corp. Is Trading At A New High For The Year - RTT News 11/05/2009 10:48AM |
Consensus Recommendation |
|
Analyst Info |
|
| Annual EPS Est: | $ 2.95 |
| Quarterly EPS Est: | $ 0.71 |
| PEG Ratio: | 1.26 |
| Mean Recommendation: View Summary/View All |
1.73 |
